Hanmi-Pharm-goes-down-1.74%

As of Apr. 5 10:10 A.M., Hanmi Pharm declined 1.74 percent, compared with yesterday, to 452,000 won. It had declined 6.51 percent through the past month.

Compared with its close competitors within the same industry, KOSPI, even though the monthly earnings rate of Hanmi Pharm stayed negative, its volatility for 1 month was at the lowest level.

Comparing industry to the market, the KOSPI industry including Hanmi Pharm records lower volatility but a higher earning rate than Medical Supplies. In other words, the industry had been safer with high returns.

Target price 594,000 won

Per analysts’ expectations during the recent month, the average target price of HanmiPharm is 594,000 won. The stock price is 452,000 won as of yesterday, so there is 142,000 won (31 percent) disparate in order to be able to increase.

Foreigners buy

From Apr. 03, Institutions have been continuously selling Hanmi Pharm during the past two trading days.

As a shareholding sum by the investor group for the past four weeks, Foreigners have bought 81,288 shares with the maintenance of shareholding and Individuals have bought 57,293 shares lessening its position.

However, during the same period, Institutions have sold 138,361 shares with a selling trend.

Regarding the statistics for the past month on trade volume as the total outstanding shares, the daily turnover rate of Hanmi Pharm was 0.26 percent. And the daily volatility, the average range of rise and fall, during the same period is 2.28 percent.

As per the inquiry for shareholding by the investor group, the major investor group is Institutions with 41.95 percent from total outstanding shares.

Individuals and Foreigners each hold 35.47 percent and 21.89 percent. And as recent five-day shareholding change by the investor group, Institutions is the major investor group with 42.63 percent. Individuals hold 30.38 percent and Foreigners hold 26.36 percent.

 

This article is provided by ThinkPool, a Korean artificial intelligence developer. Its AI algorithm automatically produced this article, which is edited with Google Grammarly. If there are any issues or if readers have any comments, please contact voc200@gmail.com or 82-2-6956-6698.